Palatable orodispersible formulation of vortioxetine
GEP20267905BActive Publication Date: 2026-06-25ALKALOID SKOPJE
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- GEP20267905P0
- Authority / Receiving Office
- GE · GE
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2022-09-30
- Filing Date
- 2023-09-27
- Publication Date
- 2026-06-25
- Estimated Expiration
- 2043-09-27
Abstract
Orodispersible formulation of vortioxetine hydrobromide comprises granular component, polymeric component; and extragranular matrix. Granular component comprises vortioxetine salt together with inert carrier. Granular component is encapsulated into polymeric component.
Need to check novelty before this filing date? Find Prior Art